TrialThe New England journal of medicine2015
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
Alessandro M Vannucchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
438 papers cite itlatest 60 shown
this paperpooled ittrialcites it